UnitedHealth Group (UNH) Q2 2025 10-Q Quarterly Report
UnitedHealth Group (UNH) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Aug 11, 2025 for the fiscal period ending Jun 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
UnitedHealth Group Q2 2025 10-Q Analysis
Management Discussion & Analysis
- • No quarterly revenue or YoY change data disclosed in this section
- • No profitability or margin figures provided in this section
- • No segment or product line performance details given
- • No cash position, operating cash flow, or capital deployment information included
- • Management highlights multiple risk factors and uncertainties impacting outlook without updated guidance
Risk Factors
- • No new or changed risk factors since 2024 10-K for UnitedHealth Group
- • Regulatory risk: ongoing dependence on healthcare laws and reform remains significant
- • Operational risk: exposure to competitive pressures in health insurance and services markets persists
- • Financial risk: reliance on maintaining liquidity and managing debt maturities as prior disclosed
- • Market risk: sensitivity to healthcare cost trends and policy changes continues as disclosed
UnitedHealth Group Q2 2025 Quarterly FinancialsXBRL
Revenue
$111.6B
▲ +12.9% YoY▲ +1.9% QoQ
Net Income
$3.4B
▼ -19.2% YoY▼ -45.9% QoQ
Net Margin
3.1%
▼ -121bp YoY▼ -269bp QoQ
Source: XBRL data from UnitedHealth Group Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other UnitedHealth Group Quarterly Reports
Get deeper insights on UnitedHealth Group
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.